Posting this under the heading it deserves: System suitability injections: if they failed, the run did not happen Everything below is what sits behind that.
Proposing that system suitability injections deserves a maintained page rather than a recurring topic, and drafting the skeleton here so that the argument about scope happens before the writing rather than after.
What I think belongs on it, what does not, and the three claims that would need a citation each.
That is consistent with mine, for whatever one more account is worth.
Narrowing the opening post, because the general version has more than one answer.
Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly composition-dependent. Area percent at one wavelength is not area percent at the other.
I would treat the number as indicative rather than as a measurement.
What I would check first on system suitability injections is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Taking post #4 at face value and following it one step further.
Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes across the peak. A passing peak-purity result says the spectrum is constant; it is weak evidence of homogeneity if the impurities have similar spectra.
That is where I would start, not where I would stop.
Post #3 and I disagree about the size of the effect, not about the direction.
I would be cautious about generalising from the system suitability injections example above. It is a good example. It is one example.
Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible peaks and gives a lower purity figure. Both are legitimate methods and they will not produce the same number.
Two sentences on system suitability injections and then I will stop, because the rest is speculation and the thread is better without mine.
What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.
This follows post #8 rather than contradicting it.
System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was analysed. If suitability did not pass, the sample results from that run are uninterpretable.
System suitability injections: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span a couple of percentage points on the same chromatogram.
That matches what I have seen, for whatever a single anecdote is worth.
Building on post #12 rather than restating it.
System suitability injections is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.
System suitability is not paperwork. If the replicate injections failed, the run did not happen — the numbers from it are uninterpretable rather than approximate.
That is the version I would defend. It is not the version I started with.
Post #14 and I disagree about the size of the effect, not about the direction.
Source for the system suitability injections figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.
Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.
Taking post #17 at face value and following it one step further.
A request rather than an answer: could whoever has the primary source for system suitability injections post it? I have seen the claim three times this month and each version had lost a qualifier.
A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table if the number matters.
A partial answer, offered because a partial answer beats none.
Post #17 is right about the mechanism and I think understates the practical bit.
On system suitability injections, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.
If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.
Post #19 answers the question as asked. The question underneath it is different.
Summarising the system suitability injections thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.
Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum against a specified peak, and a plate-count floor.
The short version is the first sentence; the rest is why.
Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre 250 millimetre column and a sub-2 micrometre 100 millimetre column are different instruments in practice.
I would want to see it done twice before believing it once.
The most useful reply I ever got about system suitability injections was a request to state my units. It sounds like pedantry and it has saved me twice.
Fair, and the limits you put on it are the part I will remember.
Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a ceiling on what any purity figure can claim.
I would put this at better than even and not much better.
Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method rarely reproduces retention times exactly on a different system.
Worth separating two things that post #24 runs together.
One more thing on system suitability injections that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Column chemistry choices for a 40-residue peptide
Column chemistry choices for a 40-residue peptide — setting out what I have, and where I think it stops being reliable. Collecting what is known about column chemistry choices in one place, because it is…
|
+39 | 43 | 1.1k | 10mo |
|
Coming back to: Column chemistry choices for a 40-residue peptide
On the subject in the title: Column chemistry choices for a 40-residue peptide Working notes rather than a conclusion. Column chemistry choices — I have the observation and I do not trust my interpretation of…
|
2 | 43k | 16mo | |
|
About the HPLC & UHPLC category
Reversed-phase separations, gradients, columns, integration, and reading a chromatogram properly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 137 | 18h | |
|
[2026 update] Area percent versus weight percent: the confusion that causes most arguments
On the subject in the title: Area percent versus weight percent: the confusion that causes most arguments Working notes rather than a conclusion. Proposing that Area percent versus weight percent deserves a…
|
+65 | 70 | 1.1k | 16d |
|
What a reversed-phase purity number actually is — the long version
What a reversed-phase purity number actually is — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means…
|
2 | 15k | 8mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Pen wastage and its effect on real cost — the long version
Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. A narrow question about Pen wastage, deliberately narrow,…
|
2 | 34k | 13mo | |
|
Contributing data without breaching anyone's privacy — what changed since
On the subject in the title: Contributing data without breaching anyone's privacy — what changed since Working notes rather than a conclusion. What changes if the standard account of Contributing data without…
|
2 | 58k | 17mo | |
|
[2026 update] Waist circumference technique and its repeatability
Posting this under the heading it deserves: Waist circumference technique and its repeatability Everything below is what sits behind that. An honest uncertainty about Waist circumference technique rather than…
|
+23 | 27 | 5.9k | 21h |
|
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold?
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. An honest uncertainty about…
|
+14 | 18 | 3.4k | 2mo |
|
About the Progress reports category
Longitudinal self-reports with the method stated. Scales, tape measures, and their error bars. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
|
4 | 139 | 16mo |